Pomalidomide is targeted Therapy
which is used in the treatment of Multiple Myeloma patients. Pomalidomide is a
derivative of Thalidomide. This product is marketed by Celgene. Pomalidomide is
anti angiogenic and also acts as an Immunomodulator. Pomalidomide is being marketed
as Pomalyst in the U.S. and Imnovid in the Europe and Russia. This product was
approved in 2013 by USA FDA for treatment in patients with relapsed and
refractory Multiple Myeloma. Pomalidomide is available as Capsule form.
Pomalyst or Imnovid is not available in India as of now (December’ 2019). The
only option is to buy Generic version of Pomalidomide in India.
The cost of
Pomalyst will be very high as the patient requiring Pomalyst will have to
import the product on named patient supply. The Indian Government may not allow
the import of Innovator product (Pomalyst / Imnovid) if Generic is available in
India.
The 1st genetic of
Pomalidomide was approved in India by Natco Pharma in 2017. Natco introduces Pomalidomide by the brand
name of Pomalid. There are many other generic products available in India as
per following details:
2. Pomired, Dr
Reddy's Laboratories Ltd
5. Pomalex, Sun
Pharmaceutical Industries Ltd
6.
Pomide, Hetero Pharma
There are many countries where Abiraterone is not available
or approved. Patients from those countries can import medicine on named patient
bases. They have to take import permission from their Government before
importing the product. They have to provide their prescription and id proof
before importing the product. It is always better to check the credential of
the exporter before importing the product.
Generic medicine is a broad term. Patient / buyer should
check Credibility of manufacturer before buying the product.
Where can I Buy Generic Pomalidomide 4 mg in India?
Patients from all over the world can buy generic pomalidomide 4 mg
from Pharmacy shops in India. Patients need to consult Hematologist /
Oncologists / Physician before starting treatment.
Can we buy Pomalidomide online?
Pomalidomide is a prescription medicine. The patent should
start treatment with Pomalidomide after consultation with treating Physician